Stock Region Watchlist
Stock Region Watchlist Newsletter - Thursday, April 17, 2025.
Stock Region Watchlist Newsletter - Thursday, April 17, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is intended for informational purposes only and does not constitute financial advice. Please conduct your own research or consult with a financial advisor before making any investment decisions.
Hertz ($HTZ)
Investor Confidence
Hertz shares experienced a substantial surge, climbing over 10%, after prominent investor Bill Ackman’s Pershing Square disclosed a major stake in the company. The move sends a clear signal of strong confidence in Hertz's recovery efforts and its potential for future growth.
Market Momentum
This announcement has attracted significant market interest, making Hertz a stock to watch closely. Key levels to monitor in the short term include an upside above $7.31 and a downside below $6.32.
UnitedHealth Group ($UNH)
Earnings Report
UnitedHealth Group reported Q1 2025 earnings of $6.85 per share, with adjusted earnings at $7.20 per share. Revenue showed solid 9.5% year-over-year growth, reaching $109.6 billion, but fell short of market expectations.
Revised Guidance
Citing challenges in its Medicare Advantage operations and changes within Optum Health’s member base, UnitedHealth lowered its 2025 earnings guidance to $24.65–$25.15 per share (adjusted: $26–$26.50).
Market Reaction
The earnings miss and guidance cut led to a 20% drop in the company’s stock price. Despite this, UnitedHealth is actively addressing its operational challenges, aiming to return to its long-term growth target of 13–16%. Short-term levels to monitor are an upside above $485.00 and a downside below $461.10.
Eli Lilly ($LLY)
Pharmaceutical Leadership
Eli Lilly continues to stand out as a major force in the pharmaceutical sector, bolstered by a robust drug pipeline and steady performance.
Potential Catalysts
While there’s no significant news at the moment, Eli Lilly remains a key stock due to ongoing developments in innovative treatments and clinical trials. Watch for potential movements with upside levels above $832.80 and downside levels below $815.51.
Thank you for subscribing to the Stock Region Watchlist Newsletter. Stay informed, invest wisely!
Disclaimer: Stock Region and its contributors are not responsible for any losses incurred due to market activities. Always invest responsibly and seek professional guidance as needed.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net